LEGN - Legend Biotech Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LEGN is currently covered by 10 analysts with an average price target of $59.06. This is a potential upside of $27.28 (85.84%) from yesterday's end of day stock price of $31.78.

Legend Biotech Corp's activity chart (see below) currently has 32 price targets and 78 ratings on display. The stock rating distribution of LEGN is 98.04% BUY and 1.96% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 41.32% with an average time for these price targets to be met of 124.91 days.

Highest price target for LEGN is $90, Lowest price target is $67, average price target is $81.22.

Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 15-Apr-2025. First documented stock forecast 29-Jun-2020.

Currently out of the existing stock ratings of LEGN, 50 are a BUY (98.04%), 1 are a HOLD (1.96%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$75

$43.22 (136.00%)

$75

25 days ago
(15-Apr-2025)

4/31 (12.9%)

$41.54 (124.15%)

14

Buy

$80

$48.22 (151.73%)

$85

1 months 24 days ago
(16-Mar-2025)

6/8 (75%)

$42.06 (110.86%)

179

Buy

$78

$46.22 (145.44%)

$90

4 months 11 days ago
(29-Dec-2024)

0/4 (0%)

$45.23 (138.02%)

Buy

$76

$44.22 (139.14%)

$70

8 months 29 days ago
(11-Aug-2024)

1/3 (33.33%)

$19.75 (35.11%)

66

Buy

$67

$35.22 (110.82%)

9 months 26 days ago
(14-Jul-2024)

0/1 (0%)

$13.01 (24.10%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LEGN (Legend Biotech Corp) average time for price targets to be met?

On average it took 124.91 days on average for the stock forecasts to be realized with a an average price target met ratio 41.32

Which analyst has the current highest performing score on LEGN (Legend Biotech Corp) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on LEGN (Legend Biotech Corp)?

Justin Zelin works at BTIG and has 2 price targets and 2 ratings on LEGN

Which analyst is the currently most bullish on LEGN (Legend Biotech Corp)?

Gena Wang with highest potential upside - $62.22

Which analyst is the currently most reserved on LEGN (Legend Biotech Corp)?

Cory Kasimov with lowest potential downside - -$9.82

Legend Biotech Corp in the News

What Makes Legend Biotech (LEGN) a New Buy Stock

Legend Biotech Corporation Sponsored ADR (LEGN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates — one of the most powerful forces impacting stock prices — has triggered this rating change. The sole determinant of the Zacks rating is a company’s...

Wall Street Analysts Think Legend Biotech (LEGN) Could Surge 135.16%: Read This Before Placing a Bet

Legend Biotech Corporation Sponsored ADR (LEGN) closed the last trading session at $33.96, gaining 3.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $79.86 indicates a 135.2% upside potential. The...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?